AI brief of an SEC Form 8-K · CLEARONE INC (CLRO)

ClearOne agrees to issue 855,000 shares to four advisors tied to Vivani merger

Neutral Impact 3 of 5 m&a Written later

On August 7, 2026, ClearOne entered advisor agreements with four firms, agreeing to issue a total of 855,000 shares of common stock as compensation for past and ongoing advisory services, effective June 1, 2026. The agreements were made in connection with a July 1, 2026 merger agreement with CLRO Merger Sub, Cortigent and Vivani Medical, and the share issuance increases the number of shares outstanding. The filing also discloses related-party links, as First Finance Ltd. is a majority stockholder and a director has voting power over one advisor's shares.

Key points

  • First Finance Ltd., a majority stockholder, will receive 25,000 shares of common stock
  • Betelgeuse Capital Advisors Inc. will receive 90,000 shares, Gang3 Capital Ltd. 140,000 shares and JJK Holdings Ltd. 600,000 shares
  • Agreements dated August 7, 2026 are effective June 1, 2026 and run until services are completed or ten business days' written notice is given
  • Director Eric Boehnke, serving since June 20, 2025, holds voting and dispositive power over Gang3 Capital Ltd.'s shares

The filing

CompanyCLEARONE INC (CLRO)
Form8-K, current report
Filed with the SECAug 11, 2026, 5:21 PM ET
Accession number0001753926-26-001428

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.